Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
Clinical trial NCT05459571 · COMPLETED
Trial details
- NCT number
- NCT05459571
- Sponsor
- Kite, A Gilead Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-09
- Primary completion
- 2025-11-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.